ovariancancertrials.com Report : Visit Site


  • Server:Apache...

    The main IP address: 165.160.13.20,Your server United States,Wilmington ISP:Corporation Service Company  TLD:com CountryCode:US

    The description :astrazeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide....

    This report updates in 16-Jun-2018

Created Date:2013-12-19
Changed Date:2013-12-19
Expires Date:2018-12-19

Technical data of the ovariancancertrials.com


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host ovariancancertrials.com. Currently, hosted in United States and its service provider is Corporation Service Company .

Latitude: 39.735778808594
Longitude: -75.665702819824
Country: United States (US)
City: Wilmington
Region: Delaware
ISP: Corporation Service Company

the related websites

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

Content-Length:15861
Content-Encoding:gzip
Set-Cookie:BNI_persistence_AZ=wTSho06KL40Grkopd9Nj6nzyaBgt4z9r8qOcVNBy8eR06wQr48nAEyljrpQj2SR4sWG6cP8iqudFVpbXocG7cA==; Path=/; Max-age=1200; Expires=Fri, 15 Jun 2018 16:34:45 GMT
Accept-Ranges:bytes
Expires:Fri, 15 Jun 2018 16:16:45 GMT
Vary:Accept-Encoding
Connection:close
Server:Apache
X-Mod-Pagespeed:1.11.33.4-0
Cache-Control:public,max-age=120,max-age=0, no-cache
Date:Fri, 15 Jun 2018 16:14:45 GMT
Access-Control-Allow-Origin:https://policy.cookiereports.com
Content-Type:text/html;charset=UTF-8
X-Frame-Options:SAMEORIGIN

DNS

soa:dns1.cscdns.net. hostmaster.cscdns.net. 2013121905 28800 7200 604800 14400
ns:dns1.cscdns.net.
dns2.cscdns.net.
ipv4:IP:165.160.13.20
ASN:19574
OWNER:CSC - Corporation Service Company, US
Country:US
IP:165.160.15.20
ASN:19574
OWNER:CSC - Corporation Service Company, US
Country:US
mx:MX preference = 10, mail exchanger = custmx.cscdns.net.

HtmlToText

skip to content skip to navigation cookie policy this website uses cookies to help us give you the best experience when you visit. by using this website you consent to our use of these cookies. find out more about how we use cookies and how to manage them by reading our cookie notice. close search menu search search search close what science can do what science can do labtalk blog our technology drug modalities our science our science pipeline publications cambridge gothenburg gaithersburg imed biotech unit medimmune global medicines development our focus areas cardiovascular, renal and metabolism oncology respiratory inflammation and autoimmunity neuroscience infection and vaccines all focus areas all medicines our company our company our strategy our people leadership team careers careers global careers site investors investor relations stock exchange announcements results and presentations annual reports governance dividend policy debt investors adr programme shareholder information key facts faqs partnering partnering partnering case studies get in touch business mentoring astrazeneca exchange media media centre image library broadcast videos articles press releases archive sustainability sustainability access to healthcare environmental protection ethics and transparency resources more hide astrazeneca websites global site pioneering new approaches to drug discovery read more science story precision medicine and genomics our technology we encourage collaborative partnerships with other scientific organisations who may benefit from working with the best equipment in the field science is at the heart of everything we do. what drives you today? ground-breaking science career opportunities to partner with astrazeneca investor information ground-breaking science i have a passion to develop medicines that help patients who don’t otherwise have options. this is very rewarding and motivating for me, and keeps me focused on seeking the evidence, and collaborating with other investigators who share a similar vision to pursue the science that benefits all of mankind. roland kolbeck, phd, vice-president r&d respiratory, inflammation and autoimmunity (ria) at medimmune learn more about medimmune, our global biologics research and development arm publications our innovative science means a strong track-record of publication in peer-reviewed journals, contributing to the foundation of scientific advancement. view our publications we have 144 projects in our pipeline view pipeline colab high throughput screening system explore our technology our new facility in cambridge will be an open, welcoming and vibrant centre explore all our science centres corporate press release update on phase iii clinical trials of lanabecestat for alzheimer’s disease 12 june 2018 corporate press release the eu approves tagrisso for 1st-line treatment of egfr-mutated non-small cell lung cancer 8 june 2018 our science at astrazeneca, science is at the core of everything we do. but more than that, science is who we are. find out more career opportunities there is an expanding universe of biological data available which can revolutionise our understanding of disease and therapy if we find innovative ways to share and explore it. jonathan dry, principal scientist, bioinformatics, oncology, innovative medicines & early development meet our people acoustic mass spectrometer platform explore our technology three strategic science centres our research sites are collaborative, innovative and dynamic environments that allow our scientists to keep pushing the boundaries find our about our science inhibiting stages in the dna damage response pathway read more of our stories our focus areas cardiovascular and metabolic diseases oncology respiratory inflammation and autoimmunity neuroscience infection and vaccines astrazeneca job search at astrazeneca we are guided in our work by a strong set of values, and we’re resetting expectations of what a bio-pharmaceutical company can be. if you’re inspired by the possibilities of science to make a difference and ready to discover what you can do – join us. search for a job now start a career that will help improve life for millions. learn more about our school/college student, undergraduate, graduate and post doctorate programmes with us in our early careers page. find your early career now working at astrazeneca we need great people who share our passion for science and have the drive and determination to meet the unmet needs of patients around the world. find out more about our teams and the work they do. find out more on the careers section to partner with astrazeneca i often say being in business development is having the best job in astrazeneca in terms of the motivation, interest and challenging work we do with incredibly smart people from science and business on projects that really make a difference for our partners and patients. shaun grady, vice-president business development operations see our partnering contacts horizon discovery and astrazeneca: searching for novel, personalised cancer therapies see more partnering case studies partnering with us we partner with like-minded organisations and pursue a range of different types of opportunities that are aligned with our portfolio and areas of expertise. learn more about our areas of interest open innovation our open innovation platform is designed to foster open innovation partnerships spanning all stages of drug discovery and development. learn more on the open innovation site corporate press release astrazeneca heads to 2018 asco annual meeting with its diversified oncology portfolio and next-generation pipeline 24 may 2018 corporate press release updated overall survival data for lynparza in brca-mutated her2-negative metastatic breast cancer presented at aacr 15 april 2018 collaborate with us the best science doesn't happen in isolation. visit our partnering section investor information “encouraging launches and strong performances from our newer generation of medicines made a significant contribution to product sales in the quarter, paving the way for our anticipated return to growth in 2018. the performance was in line with our expectations and guidance for the year is unchanged." pascal soriot, executive director and chief executive officer meet our people latest presentation q1 2018 results view quarterly results financial calendar find all the latest dates for ex-dividends, investor roadshows and more see all key dates latest financial information see all the results and presentations read the latest annual report (2017) stock exchange announcements find all the latest announcements from the stock exchange view latest announcements corporate press release update on phase iii clinical trials of lanabecestat for alzheimer’s disease 12 june 2018 corporate press release the eu approves tagrisso for 1st-line treatment of egfr-mutated non-small cell lung cancer 8 june 2018 investors find out more about investing in astrazeneca, everything from investor relations to dividend policies. visit our investor relations astrazeneca websites this website is intended for people seeking information on astrazeneca's worldwide business. our country sites can be located in the az network. resources all resources open innovation externally sponsored scientific research medimmune us prescription assistance programmes global clinical trials information medicines report a possible side effect pearl therapeutics quick links media investor relations partnering careers sustainability modern slavery statement supplier information social media facebook linkedin twitter glassdoor utility links legal notice and terms of use privacy notice cookie policy site map contact us © astrazeneca 2018 you are now leaving astrazeneca.com you have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. astrazeneca provides this link as a service to website vis

URL analysis for ovariancancertrials.com


https://www.astrazeneca.com///our-company.html
https://www.astrazeneca.com///our-science.html
https://www.astrazeneca.com///investor-relations/results-and-presentations.html
https://www.astrazeneca.com///our-company/contact-us.html
https://www.astrazeneca.com///investor-relations/astrazeneca-adr-programme.html
https://www.astrazeneca.com///sustainability/ethics-and-transparency.html
https://www.astrazeneca.com///media-centre.html
https://www.astrazeneca.com///sustainability/resources.html
https://www.astrazeneca.com///our-company/our-strategy.html
https://www.astrazeneca.com///astrazeneca-exchange.html
https://www.astrazeneca.com///careers.html
https://www.astrazeneca.com///investor-relations/stock-exchange-announcements.html
https://www.astrazeneca.com///our-focus-areas/infection-and-vaccines.html
https://www.astrazeneca.com///our-science/gaithersburg.html
https://www.astrazeneca.com///our-science/imed.html
glassdoor.co.uk

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;


Domain Name: ovariancancertrials.com
Registry Domain ID: 1839725036_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: www.cscprotectsbrands.com
Updated Date: 2015-08-17T21:32:10Z
Creation Date: 2013-12-19T14:57:18Z
Registrar Registration Expiration Date: 2018-12-19T14:57:18Z
Registrar: CSC CORPORATE DOMAINS, INC.
Registrar IANA ID: 299
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8887802723
Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
Registry Registrant ID:
Registrant Name: Domains Administration
Registrant Organization: AstraZeneca AB
Registrant Street: Vastra Malarehamnen 9
Registrant City: Sodertalje
Registrant State/Province:
Registrant Postal Code: 15185
Registrant Country: SE
Registrant Phone: +46.855326000
Registrant Phone Ext:
Registrant Fax: +46.855328821
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Domains Administration
Admin Organization: AstraZeneca AB
Admin Street: Vastra Malarehamnen 9
Admin City: Sodertalje
Admin State/Province:
Admin Postal Code: 15185
Admin Country: SE
Admin Phone: +46.855326000
Admin Phone Ext:
Admin Fax: +46.855328821
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: DNS Administrator
Tech Organization: CSC Corporate Domains, Inc.
Tech Street: 2711 Centerville Rd
Tech City: Wilmington
Tech State/Province: DE
Tech Postal Code: 19808
Tech Country: US
Tech Phone: +1.3026365400
Tech Phone Ext:
Tech Fax: +1.3026365454
Tech Fax Ext:
Tech Email: [email protected]
Name Server: dns1.cscdns.net
Name Server: dns2.cscdns.net
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2015-08-17T21:32:10Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Corporation Service Company(c) (CSC) The Trusted Partner of More than 50% of the 100 Best Global Brands.

Contact us to learn more about our enterprise solutions for Global Domain Name Registration and Management, Trademark Research and Watching, Brand, Logo and Auction Monitoring, as well SSL Certificate Services and DNS Hosting.

NOTICE: You are not authorized to access or query our WHOIS database through the use of high-volume, automated, electronic processes or for the purpose or purposes of using the data in any manner that violates these terms of use. The Data in the CSC WHOIS database is provided by CSC for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. CSC does not guarantee its accuracy. By submitting a WHOIS query, you agree to abide by the following terms of use: you agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via direct mail, e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to CSC (or its computer systems). CSC reserves the right to terminate your access to the WHOIS database in its sole discretion for any violations by you of these terms of use. CSC reserves the right to modify these terms at any time.

Register your domain name at http://www.cscglobal.com

  REGISTRAR CSC CORPORATE DOMAINS, INC.

  REFERRER http://www.cscglobal.com/global/web/csc/digital-brand-services.html

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =ovariancancertrials.com

  PORT 43

  SERVER whois.corporatedomains.com

  ARGS ovariancancertrials.com

  PORT 43

  TYPE domain

DOMAIN

  NAME ovariancancertrials.com

NSERVER

  DNS1.CSCDNS.NET 209.112.114.33

  DNS2.CSCDNS.NET 69.36.145.33

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

  CHANGED 2013-12-19

  CREATED 2013-12-19

  EXPIRES 2018-12-19

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.uovariancancertrials.com
  • www.7ovariancancertrials.com
  • www.hovariancancertrials.com
  • www.kovariancancertrials.com
  • www.jovariancancertrials.com
  • www.iovariancancertrials.com
  • www.8ovariancancertrials.com
  • www.yovariancancertrials.com
  • www.ovariancancertrialsebc.com
  • www.ovariancancertrialsebc.com
  • www.ovariancancertrials3bc.com
  • www.ovariancancertrialswbc.com
  • www.ovariancancertrialssbc.com
  • www.ovariancancertrials#bc.com
  • www.ovariancancertrialsdbc.com
  • www.ovariancancertrialsfbc.com
  • www.ovariancancertrials&bc.com
  • www.ovariancancertrialsrbc.com
  • www.urlw4ebc.com
  • www.ovariancancertrials4bc.com
  • www.ovariancancertrialsc.com
  • www.ovariancancertrialsbc.com
  • www.ovariancancertrialsvc.com
  • www.ovariancancertrialsvbc.com
  • www.ovariancancertrialsvc.com
  • www.ovariancancertrials c.com
  • www.ovariancancertrials bc.com
  • www.ovariancancertrials c.com
  • www.ovariancancertrialsgc.com
  • www.ovariancancertrialsgbc.com
  • www.ovariancancertrialsgc.com
  • www.ovariancancertrialsjc.com
  • www.ovariancancertrialsjbc.com
  • www.ovariancancertrialsjc.com
  • www.ovariancancertrialsnc.com
  • www.ovariancancertrialsnbc.com
  • www.ovariancancertrialsnc.com
  • www.ovariancancertrialshc.com
  • www.ovariancancertrialshbc.com
  • www.ovariancancertrialshc.com
  • www.ovariancancertrials.com
  • www.ovariancancertrialsc.com
  • www.ovariancancertrialsx.com
  • www.ovariancancertrialsxc.com
  • www.ovariancancertrialsx.com
  • www.ovariancancertrialsf.com
  • www.ovariancancertrialsfc.com
  • www.ovariancancertrialsf.com
  • www.ovariancancertrialsv.com
  • www.ovariancancertrialsvc.com
  • www.ovariancancertrialsv.com
  • www.ovariancancertrialsd.com
  • www.ovariancancertrialsdc.com
  • www.ovariancancertrialsd.com
  • www.ovariancancertrialscb.com
  • www.ovariancancertrialscom
  • www.ovariancancertrials..com
  • www.ovariancancertrials/com
  • www.ovariancancertrials/.com
  • www.ovariancancertrials./com
  • www.ovariancancertrialsncom
  • www.ovariancancertrialsn.com
  • www.ovariancancertrials.ncom
  • www.ovariancancertrials;com
  • www.ovariancancertrials;.com
  • www.ovariancancertrials.;com
  • www.ovariancancertrialslcom
  • www.ovariancancertrialsl.com
  • www.ovariancancertrials.lcom
  • www.ovariancancertrials com
  • www.ovariancancertrials .com
  • www.ovariancancertrials. com
  • www.ovariancancertrials,com
  • www.ovariancancertrials,.com
  • www.ovariancancertrials.,com
  • www.ovariancancertrialsmcom
  • www.ovariancancertrialsm.com
  • www.ovariancancertrials.mcom
  • www.ovariancancertrials.ccom
  • www.ovariancancertrials.om
  • www.ovariancancertrials.ccom
  • www.ovariancancertrials.xom
  • www.ovariancancertrials.xcom
  • www.ovariancancertrials.cxom
  • www.ovariancancertrials.fom
  • www.ovariancancertrials.fcom
  • www.ovariancancertrials.cfom
  • www.ovariancancertrials.vom
  • www.ovariancancertrials.vcom
  • www.ovariancancertrials.cvom
  • www.ovariancancertrials.dom
  • www.ovariancancertrials.dcom
  • www.ovariancancertrials.cdom
  • www.ovariancancertrialsc.om
  • www.ovariancancertrials.cm
  • www.ovariancancertrials.coom
  • www.ovariancancertrials.cpm
  • www.ovariancancertrials.cpom
  • www.ovariancancertrials.copm
  • www.ovariancancertrials.cim
  • www.ovariancancertrials.ciom
  • www.ovariancancertrials.coim
  • www.ovariancancertrials.ckm
  • www.ovariancancertrials.ckom
  • www.ovariancancertrials.cokm
  • www.ovariancancertrials.clm
  • www.ovariancancertrials.clom
  • www.ovariancancertrials.colm
  • www.ovariancancertrials.c0m
  • www.ovariancancertrials.c0om
  • www.ovariancancertrials.co0m
  • www.ovariancancertrials.c:m
  • www.ovariancancertrials.c:om
  • www.ovariancancertrials.co:m
  • www.ovariancancertrials.c9m
  • www.ovariancancertrials.c9om
  • www.ovariancancertrials.co9m
  • www.ovariancancertrials.ocm
  • www.ovariancancertrials.co
  • ovariancancertrials.comm
  • www.ovariancancertrials.con
  • www.ovariancancertrials.conm
  • ovariancancertrials.comn
  • www.ovariancancertrials.col
  • www.ovariancancertrials.colm
  • ovariancancertrials.coml
  • www.ovariancancertrials.co
  • www.ovariancancertrials.co m
  • ovariancancertrials.com
  • www.ovariancancertrials.cok
  • www.ovariancancertrials.cokm
  • ovariancancertrials.comk
  • www.ovariancancertrials.co,
  • www.ovariancancertrials.co,m
  • ovariancancertrials.com,
  • www.ovariancancertrials.coj
  • www.ovariancancertrials.cojm
  • ovariancancertrials.comj
  • www.ovariancancertrials.cmo
Show All Mistakes Hide All Mistakes